Pfizer final analysis of Phase 3 study indicates COVID-19 vaccine efficacy rate of 95%

Based on current projections, Pfizer and BioNTech expect to produce globally up to 50 million COVID-19 vaccine doses in 2020 and up to 1.3 billion coronavirus doses by the end of 2021. 

from Zee News :Zee News - Health https://ift.tt/36M4DGn
via IFTTT